iRhythm Technologies Unveils New Data Showing Consistent Zio LTCM Performance in Asian Patients
Reuters
Nov 21
iRhythm Technologies Unveils New Data Showing Consistent Zio LTCM Performance in Asian Patients
iRhythm Technologies Inc. has announced new data presented at the 18th Asia Pacific Heart Rhythm Society (APHRS) and Japanese Heart Rhythm Society (JHRS) 2025 Joint Scientific Session in Yokohama, Japan, held November 12-15. The study, led by Dr. Hiro Kawata, compared device compliance, performance, arrhythmia detection, and repeat-testing rates between Asian and non-Asian populations in a large cohort of 408,470 U.S. patients monitored with iRhythm's Zio long-term continuous ECG monitoring (LTCM) service from 2018 to 2022. The results demonstrated that median wear and analyzable time among Asian patients were comparable to those of non-Asian patients, and the findings were consistent with previously published studies. iRhythm is also collaborating with investigators in Japan to further expand evidence across local patient populations and clinical settings.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRhythm Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9580184-en) on November 21, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.